381 related articles for article (PubMed ID: 29712884)
1. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in cardiovascular disease.
Lezutekong JN; Nikhanj A; Oudit GY
Clin Sci (Lond); 2018 Apr; 132(8):901-904. PubMed ID: 29712884
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
Sata Y; Marques FZ; Kaye DM
Curr Hypertens Rep; 2020 May; 22(5):38. PubMed ID: 32385705
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
4. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates.
Vemuri R; Ruggiero A; Whitfield JM; Dugan GO; Cline JM; Block MR; Guo H; Kavanagh K
Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H474-H485. PubMed ID: 35148233
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the gut microbiome and mucosal immune system.
Shi N; Li N; Duan X; Niu H
Mil Med Res; 2017; 4():14. PubMed ID: 28465831
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
7. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
8. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
9. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota and blood pressure in experimental models.
Jama HA; Kaye DM; Marques FZ
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
[TBL] [Abstract][Full Text] [Related]
11. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
Kim S; Goel R; Kumar A; Qi Y; Lobaton G; Hosaka K; Mohammed M; Handberg EM; Richards EM; Pepine CJ; Raizada MK
Clin Sci (Lond); 2018 Mar; 132(6):701-718. PubMed ID: 29507058
[TBL] [Abstract][Full Text] [Related]
12. [Microbiome, diabetes and heart: a novel link?].
Kappel BA; Lehrke M
Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.
Meisel M; Mayassi T; Fehlner-Peach H; Koval JC; O'Brien SL; Hinterleitner R; Lesko K; Kim S; Bouziat R; Chen L; Weber CR; Mazmanian SK; Jabri B; Antonopoulos DA
ISME J; 2017 Jan; 11(1):15-30. PubMed ID: 27648810
[TBL] [Abstract][Full Text] [Related]
14. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome over a Lifetime and the Association with Hypertension.
Yano Y; Niiranen TJ
Curr Hypertens Rep; 2021 Mar; 23(3):15. PubMed ID: 33686539
[TBL] [Abstract][Full Text] [Related]
16. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Brandl K; Schnabl B
Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
Wei YX; Zheng KY; Wang YG
World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
[TBL] [Abstract][Full Text] [Related]
19. The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans.
Maiuolo J; Carresi C; Gliozzi M; Mollace R; Scarano F; Scicchitano M; Macrì R; Nucera S; Bosco F; Oppedisano F; Ruga S; Coppoletta AR; Guarnieri L; Cardamone A; Bava I; Musolino V; Paone S; Palma E; Mollace V
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409057
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiome, Energy Homeostasis, and Implications for Hypertension.
Riedl RA; Atkinson SN; Burnett CML; Grobe JL; Kirby JR
Curr Hypertens Rep; 2017 Apr; 19(4):27. PubMed ID: 28316052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
